Heartbeam Stock Today
| BEAT Stock | USD 2.05 0.03 1.49% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Heartbeam is selling for under 2.05 as of the 16th of March 2025; that is 1.49 percent increase since the beginning of the trading day. The stock's last reported lowest price was 2.0. Heartbeam has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 11th of November 2021 | Category Healthcare | Classification Health Care |
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company was incorporated in 2015 and is headquartered in Santa Clara, California. The company has 33.73 M outstanding shares of which 218.51 K shares are currently shorted by private and institutional investors with about 1.8 trading days to cover. More on Heartbeam
Moving against Heartbeam Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Heartbeam Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Executive Chairman | Richard Ferrari | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Health Care, Health Care Equipment & Supplies, Health Information Services, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsHeartbeam can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Heartbeam's financial leverage. It provides some insight into what part of Heartbeam's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Heartbeam (BEAT) is traded on NASDAQ Exchange in USA. It is located in 2118 Walsh Avenue, Santa Clara, CA, United States, 95050 and employs 20 people. Heartbeam is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 69.14 M. Heartbeam conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 33.73 M outstanding shares of which 218.51 K shares are currently shorted by private and institutional investors with about 1.8 trading days to cover.
Heartbeam currently holds about 9.27 M in cash with (14.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.16.
Check Heartbeam Probability Of Bankruptcy
Ownership AllocationHeartbeam has a total of 33.73 Million outstanding shares. Heartbeam secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Heartbeam Ownership Details
Heartbeam Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Blackrock Inc | 2024-12-31 | 74.8 K | |
| Spectrum Asset Management Inc | 2024-12-31 | 74.4 K | |
| Advisory Research Inc | 2024-12-31 | 50 K | |
| Northern Trust Corp | 2024-12-31 | 49.5 K | |
| Susquehanna International Group, Llp | 2024-12-31 | 43.6 K | |
| D'orazio & Associates Inc | 2024-12-31 | 33 K | |
| Smart Wealth Llc | 2024-12-31 | 25 K | |
| Lpl Financial Corp | 2024-12-31 | 21.7 K | |
| Charles Schwab Investment Management Inc | 2024-12-31 | 14.5 K | |
| Vanguard Group Inc | 2024-12-31 | 763.7 K | |
| Smith, Salley & Associates, Llc | 2024-12-31 | 250 K |
Heartbeam Historical Income Statement
Heartbeam Stock Against Markets
Heartbeam Corporate Management
| Branislav Vajdic | President, Founder | Profile | |
| FACC MD | Chief Officer | Profile | |
| Timothy Cruickshank | Chief Officer | Profile | |
| Richard Brounstein | CFO Treasurer | Profile | |
| Richa Gujarati | Senior Product | Profile | |
| Kenneth Persen | Chief Officer | Profile |
Additional Tools for Heartbeam Stock Analysis
When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.